Evidence map›Paper›PMID 39682302›Full record

ArticleCancers2024

Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.

Enrique Almanza-Aguilera, Miriam Martínez-Huélamo, Yamilé López-Hernández, Daniel Guiñón-Fort, Anna Guadall, Meryl Cruz, Aurora Perez-Cornago, Agnetha L Rostgaard-Hansen, Anne Tjønneland, Christina C Dahm and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Enrique Almanza-AguileraUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
Miriam Martínez-HuélamoCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-7650-4016
Yamilé López-HernándezThe Metabolomics Innovation Centre, University of Alberta, Edmonton, AB T6G 1C9, Canada.
Daniel Guiñón-FortUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
Anna GuadallCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-7821-8582
Meryl CruzCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-8327-4220
Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
Agnetha L Rostgaard-HansenDanish Cancer Society Research Center, Diet, Cancer and Health, 2100 Copenhagen, Denmark.ORCID 0000-0001-5731-1772
Anne TjønnelandDanish Cancer Society Research Center, Diet, Cancer and Health, 2100 Copenhagen, Denmark.ORCID 0000-0003-4385-2097
Christina C DahmDepartment of Public Health, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0003-0481-2893
Verena KatzkeDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam Rehbruecke, 14558 Nuthetal, Germany.ORCID 0000-0002-0830-5277
Giovanna MasalaClinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.ORCID 0000-0002-5758-9069
Claudia AgnoliDepartment of Research Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, 20133 Milan, Italy.
Rosario TuminoHyblean Association for Epidemiological Research, Associazione Iblea per la Ricerca Epidemiologica (AIRE-ONLUS), 97100 Ragusa, Italy.ORCID 0000-0003-2666-414X
Fulvio RicceriCentre for Biostatistics, Epidemiology, and Public Health (C-BEPH, Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043 Turin, Italy.ORCID 0000-0001-8749-9737
Cristina LasherasDepartment of Functional Biology, Oviedo University, 33003 Oviedo, Spain.ORCID 0000-0003-0482-4229
Marta Crous-BouUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
Maria-Jose SánchezEscuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.ORCID 0000-0003-4817-0757
Amaia Aizpurua-AtxegaSub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, 20013 San Sebastian, Spain.
Marcela GuevaraCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.ORCID 0000-0001-9242-6364
Kostas K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, London SW7 2AZ, UK.ORCID 0000-0002-8452-8472
Anastasia Chrysovalantou ChatziioannouInternational Agency for Research on Cancer (IARC/WHO), 69366 Lyon, France.ORCID 0000-0002-1973-7542
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC/WHO), 69366 Lyon, France.ORCID 0000-0003-2237-0128
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
David S WishartThe Metabolomics Innovation Centre, University of Alberta, Edmonton, AB T6G 1C9, Canada.ORCID 0000-0002-3207-2434
Cristina Andrés-LacuevaCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-8494-4978
Raul Zamora-RosUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.ORCID 0000-0002-6236-6804

Funding

Cancer Research UK 29017La Marató de TV-3 201943-30 and 201943-31World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EPICnested case–controlnutrimetabolomicsprostate cancer

Identifiers

PMID39682302
PMCPMC11639937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.